AffiniaTX

Biotechnology · Rare Disease Therapeutics

Overview

Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines for people.

Funding and backers

Team
51-200
employees, estimated range
Backers
6
Atlas Venture, EcoR1 Capital
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 2020 Website went live first capture in the Wayback Machine
Backed byfrom the funds' portfolios and accelerator catalogs
Atlas Venture fund EcoR1 Capital fund Eight Roads fund F-Prime Capital fund GV fund NEA fund
Investors in similar startupsfunds that back the companies most like this one
Insight Partners
backs Cirsium Biosciences
RA Capital Management
backs Ambros Therapeutics
Columbus Venture Partners
backs Viralgen
Similar startupsby what they do, their industry and backers
Myosana TherapeuticsSeed $5M · 3 yr ago · Founded 2018 · 11-50 employees
Myosana Therapeutics is one of the pioneering companies in non-viral gene therapy for neuromuscular and cardiac diseases.
Ambros Therapeutics201-500 employees
Overview. Ambros Therapeutics, headquartered in San Diego, California, is a clinical-stage biotechnology company focused on the development…
EurekaBioSeries B $40M · 2 yr ago
EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of…
Code Biotherapeutics51-200 employees
Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to…
ViralgenFounded 2017
At Viralgen, we're proud to be known for just one thing: Being a world leader in AAV-based gene therapy manufacturing.. We're all in on…
Siren BiotechnologyVenture round $19.6M · 2 yr ago · Founded 2020 · 11-50 employees
SAN FRANCISCO, CA [Jan. 28, 2026] – Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors5
Atlas VentureVia a fund
55 portfolio companies: Show + Tell, LifeSciVC, Vima Therapeutics and 52 more
EcoR1 CapitalVia a fund
69 portfolio companies: Unity Biotechnology, Terremoto Bio, zapprx.com and 66 more
F-Prime CapitalVia a fund
194 portfolio companies: AblePay Health, Arboretum LifeSciences, Inc., Arexera Therapeutics and 191 more
Eight RoadsVia a fund
234 portfolio companies: Smarter supply chains benefit everyone Inc, Zomentum, Zpeer and 231 more
GVVia a fund
569 portfolio companies
Show all 5
Report a mistake